News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,864 Results
Type
Article (40014)
Company Profile (250)
Press Release (664599)
Multimedia
Podcasts (59)
Webinars (14)
Section
Business (204278)
Career Advice (2011)
Deals (35453)
Drug Delivery (95)
Drug Development (81141)
Employer Resources (172)
FDA (16249)
Job Trends (14887)
News (345504)
Policy (32606)
Tag
Academia (2556)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49569)
ALS (108)
Alzheimer's disease (1441)
Antibody-drug conjugate (ADC) (151)
Approvals (16246)
Artificial intelligence (310)
Autoimmune disease (28)
Automation (19)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (122)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (365)
Cancer (2862)
Cardiovascular disease (212)
Career advice (1682)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (499)
Cervical cancer (22)
Clinical research (66852)
Collaboration (1012)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2624)
CRISPR (56)
C-suite (325)
Cystic fibrosis (112)
Data (2992)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (346)
Diagnostics (6424)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87451)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113739)
Executive appointments (845)
FDA (17895)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (930)
Gene editing (129)
Generative AI (22)
Gene therapy (373)
GLP-1 (780)
Government (4501)
Grass and pollen (4)
Guidances (181)
Healthcare (18839)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (146)
Immuno-oncology (8)
Indications (39)
Infectious disease (2796)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (312)
IPO (16591)
IRA (44)
Job creations (3637)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (492)
Leadership (19)
Legal (7929)
Liver cancer (79)
Longevity (11)
Lung cancer (400)
Lymphoma (208)
Machine learning (11)
Management (58)
Manufacturing (386)
MASH (90)
Medical device (13462)
Medtech (13467)
Mergers & acquisitions (19581)
Metabolic disorders (847)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (113)
Neuropsychiatric disorders (32)
Neuroscience (2116)
NextGen: Class of 2025 (6517)
Non-profit (4488)
Now hiring (47)
Obesity (427)
Opinion (218)
Ovarian cancer (101)
Pain (105)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (297)
Patient recruitment (164)
Peanut (50)
People (57685)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20828)
Phase II (29447)
Phase III (21917)
Pipeline (1632)
Policy (199)
Postmarket research (2563)
Preclinical (8870)
Press Release (64)
Prostate cancer (140)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (457)
Real estate (5918)
Recruiting (66)
Regulatory (22626)
Reports (50)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (157)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3588)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (37)
Vaccines (778)
Venture capital (54)
Weight loss (256)
Women's health (47)
Worklife (16)
Date
Today (49)
Last 7 days (364)
Last 30 days (1865)
Last 365 days (31224)
2025 (16756)
2024 (35221)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28572)
2011 (29263)
2010 (27328)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38208)
Australia (6232)
California (7433)
Canada (2358)
China (670)
Colorado (320)
Connecticut (318)
Delaware (192)
Europe (82103)
Florida (1116)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (637)
India (27)
Indiana (361)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1021)
Massachusetts (5524)
Michigan (246)
Minnesota (450)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2074)
New Mexico (28)
New York (2083)
North Carolina (1079)
North Dakota (8)
Northern California (3273)
Ohio (236)
Oklahoma (16)
Oregon (34)
Pennsylvania (1610)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2780)
Tennessee (126)
Texas (1125)
United States (27543)
Utah (220)
Virginia (184)
Washington D.C. (72)
Washington State (631)
West Virginia (4)
Wisconsin (66)
704,864 Results for "idx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
REALM IDx Announces National Health Coverage of GenMineTOP™ Cancer Genome Profiling System in Japan
REALM IDx, Inc., a health care company pioneering the field of integrated diagnostics, announced that GenMineTOP Cancer Genome Profiling System has been awarded national health coverage in Japan and will begin full commercial launch of contract testing with strategic partner, LSI Medicine Corporation.
August 1, 2023
·
3 min read
Biotech Beach
REALM IDx Launches REALM Pharma Services to Improve Drug Development and Research
REALM IDx announced the launch of REALM Pharma Services, an end-to-end discovery, translational research, and clinical trial service for biotechnology and pharmaceutical partners.
June 1, 2023
·
3 min read
Deals
Leica Biosystems Acquires Cell IDx, Moving its Multiplexing Menu Forward with Ready-to-Use, Pre-Kitted Formulations
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling.
November 8, 2022
·
3 min read
Press Releases
Pierre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
Press Releases
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
July 15, 2025
·
13 min read
Biotech Bay
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced their companies’ selection by the University of California, Irvine and the GREGoR Consortium to support the Pediatric Mendelian Genomics Research Center program to better understand the underlying biology of rare diseases.
May 15, 2024
·
6 min read
Biotech Beach
REALM IDx™ to Participate Virtually in the 40th Annual J.P. Morgan Health Care Conference
REALM IDx, Inc., a leader in integrated diagnostics, announced the company will participate in the upcoming 40th Annual J.P. Morgan Health Care Conference.
January 6, 2022
·
1 min read
Press Releases
CoRegen, Inc. Closes More Than $93 Million Financing
July 10, 2025
·
3 min read
Press Releases
CorMedix inc. Announces Customer Implementation
June 23, 2025
·
3 min read
Biotech Beach
Konica Minolta Precision Medicine Announces Name Change to REALM IDx™
Konica Minolta Precision Medicine (KMPM), a majority-owned subsidiary of Konica Minolta, Inc., announced today that it has changed its name to REALM IDx, Inc.
September 15, 2021
·
1 min read
1 of 70,487
Next
